| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $64.8M | -15.1% |
| Cost of Revenue | $20.5M | -15.1% |
| Gross Profit | $44.3M | -15.1% |
| R&D Expense | $6.7M | -18.4% |
| SG&A Expense | $36.5M | -11.2% |
| Operating Income | -$27.2M | +4.0% |
| Interest Expense | $6.9M | -0.1% |
| Pre-tax Income | -$47.6M | -28.2% |
| Income Tax | -$611K | -760.6% |
| Net Income | -$47.0M | -26.2% |
| EPS (Basic) | -$71.21 | -941.1% |
| EPS (Diluted) | -$71.21 | -941.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -20.8% |
| Accounts Receivable | $18.7M | -35.8% |
| Inventory | $17.6M | -23.9% |
| Current Assets | $48.5M | -27.0% |
| Total Assets | $68.2M | -27.2% |
| Current Liabilities | $30.3M | -2.8% |
| Long-term Debt | $31.4M | -55.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.1M | +13.9% |
| Capital Expenditures | $123K | +6.0% |
| Investing Cash Flow | -$123K | -6.0% |
| Financing Cash Flow | $10.1M | +48.0% |
| Free Cash Flow | -$11.2M | +13.8% |
| Total Liabilities |
| $65.3M |
| -39.0% |
| Stockholders' Equity | $2.4M | +116.9% |